The FDA’s recent reorganization illustrates the value of transparency—radical or otherwise—to industry and consumers alike. In the wake of an infant formula crisis that justifiably incensed the public and lawmakers, the agency relied on extensive hearings, culminating in an expert report commissioned by the Reagan-Udall Foundation.